These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17447098)

  • 41. Restrictive cardiomyopathy with kappa light chain deposits in myocardium as a complication of multiple myeloma. Histochemical and electron microscopic observations.
    McAllister HA; Seger J; Bossart M; Ferrans VJ
    Arch Pathol Lab Med; 1988 Nov; 112(11):1151-4. PubMed ID: 3140760
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Infiltrative cardiomyopathy and beta fibrillosis caused by kappa light chains (primary amyloidosis) without myeloma].
    Reyes PA; Hidalgo MA; Huerta D; Bialostozky D
    Arch Inst Cardiol Mex; 1983; 53(1):17-22. PubMed ID: 6409015
    [No Abstract]   [Full Text] [Related]  

  • 43. [Obstructive cardiomyopathy, caused by amyloidosis, associated with bone marrow myeloma].
    Rusznák M; Jakó J; Francz M; Babicz T
    Orv Hetil; 1993 May; 134(19):1033-6. PubMed ID: 8493032
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [71-year-old patient with cardiac decompensation and cardiomegaly. Unexpected diagnostic change].
    Altmann C; Staubach P; Sack R
    Internist (Berl); 1994 Jun; 35(6):564-7. PubMed ID: 8071029
    [No Abstract]   [Full Text] [Related]  

  • 45. Electron and immuno-electron microscopy of abdominal fat identifies and characterizes amyloid fibrils in suspected cardiac amyloidosis.
    Arbustini E; Verga L; Concardi M; Palladini G; Obici L; Merlini G
    Amyloid; 2002 Jun; 9(2):108-14. PubMed ID: 12440483
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
    Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
    Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Light chain cardiac amyloidosis - a rare cause of heart failure in a young adult.
    Domingues K; Saraiva M; Marta L; Monteiro I; Leal M
    Rev Assoc Med Bras (1992); 2018 Sep; 64(9):787-790. PubMed ID: 30672998
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunoglobulin-related (AL) amyloidosis.
    Husby G
    Clin Exp Rheumatol; 1983; 1(4):353-8. PubMed ID: 6442636
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis.
    Bochtler T; Hegenbart U; Heiss C; Benner A; Cremer F; Volkmann M; Ludwig J; Perz JB; Ho AD; Goldschmidt H; Schonland SO
    Haematologica; 2008 Mar; 93(3):459-62. PubMed ID: 18287137
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know].
    Arbustini E; Gavazzi A; Merlini G
    Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Strong transthyretin immunostaining: potential pitfall in cardiac amyloid typing.
    Satoskar AA; Efebera Y; Hasan A; Brodsky S; Nadasdy G; Dogan A; Nadasdy T
    Am J Surg Pathol; 2011 Nov; 35(11):1685-90. PubMed ID: 21945954
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bone marrow core biopsy specimens in AL (primary) amyloidosis. A morphologic and immunohistochemical study of 100 cases.
    Swan N; Skinner M; O'Hara CJ
    Am J Clin Pathol; 2003 Oct; 120(4):610-6. PubMed ID: 14560572
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Complexities and Pitfalls in Cardiac Amyloidosis.
    Cuddy SAM; Dorbala S; Falk RH
    Circulation; 2020 Jul; 142(4):409-415. PubMed ID: 32718247
    [No Abstract]   [Full Text] [Related]  

  • 54. Renal manifestations of plasma cell dyscrasias: an appraisal from the patients' bedside to the research laboratory.
    Herrera GA
    Ann Diagn Pathol; 2000 Jun; 4(3):174-200. PubMed ID: 10919389
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Al amyloidosis.
    Desport E; Bridoux F; Sirac C; Delbes S; Bender S; Fernandez B; Quellard N; Lacombe C; Goujon JM; Lavergne D; Abraham J; Touchard G; Fermand JP; Jaccard A;
    Orphanet J Rare Dis; 2012 Aug; 7():54. PubMed ID: 22909024
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Classification of cardiac amyloidosis: an immunohistochemical analysis].
    Li L; Duan XJ; Sun Y; Lu Y; Xu HY; Wang QZ; Wang HY
    Zhonghua Bing Li Xue Za Zhi; 2018 Feb; 47(2):105-109. PubMed ID: 29429161
    [No Abstract]   [Full Text] [Related]  

  • 57. Cardiac amyloidoma with IgM-kappa gammopathy.
    Warner KJ; Blackwell GG; Herrera GA; Listinsky C; Holman WL; Rustagi PK
    Arch Pathol Lab Med; 1994 Nov; 118(11):1148-50. PubMed ID: 7979903
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Senile cardiac amyloidosis: Clinical manifestations and non-invasive diagnostic approach.
    Varvarousis D; Polytarchou K; Daskalopoulos N; Mantas I
    Hellenic J Cardiol; 2017; 58(1):60-64. PubMed ID: 28163147
    [No Abstract]   [Full Text] [Related]  

  • 59. Immunoglobulin light and heavy chain amyloidosis AL/AH: renal pathology and differential diagnosis.
    Picken MM
    Contrib Nephrol; 2007; 153():135-55. PubMed ID: 17075228
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition.
    Biolo A; Ramamurthy S; Connors LH; O'Hara CJ; Meier-Ewert HK; Soo Hoo PT; Sawyer DB; Seldin DC; Sam F
    Circ Heart Fail; 2008 Nov; 1(4):249-57. PubMed ID: 19808299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.